Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for Neuroone Medical Technologies (NMTC) over the last 4 years, with Q4 2025 value amounting to $36417.0.

  • Neuroone Medical Technologies' Gains from Sales and Divestitures fell 368.17% to $36417.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $36417.0, marking a year-over-year decrease of 368.17%. This contributed to the annual value of $397900.0 for FY2025, which is 4718.88% up from last year.
  • Neuroone Medical Technologies' Gains from Sales and Divestitures amounted to $36417.0 in Q4 2025, which was down 368.17% from $397900.0 recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Gains from Sales and Divestitures ranged from a high of $397900.0 in Q3 2025 and a low of $36417.0 during Q4 2025
  • Over the past 4 years, Neuroone Medical Technologies' median Gains from Sales and Divestitures value was $251428.0 (recorded in 2024), while the average stood at $203156.9.
  • In the last 5 years, Neuroone Medical Technologies' Gains from Sales and Divestitures surged by 71672.9% in 2023 and then plummeted by 2093.99% in 2024.
  • Neuroone Medical Technologies' Gains from Sales and Divestitures (Quarter) stood at $40624.0 in 2022, then dropped by 7.25% to $37679.0 in 2023, then grew by 0.35% to $37809.0 in 2024, then fell by 3.68% to $36417.0 in 2025.
  • Its last three reported values are $36417.0 in Q4 2025, $397900.0 for Q3 2025, and $362129.0 during Q2 2025.